Inari Medical, which makes minimally invasive medical devices for venous diseases, raised $156 million by offering 8.2 million shares at $19, above the upwardly revised range of $17 to $18. The company had originally filed to offer 7.3 million shares at a range of $14 to $16. Insiders had indicated on $20 million of the IPO. Inari Medical plans to list on the Nasdaq under the symbol NARI. BofA Securities and Morgan Stanley acted as lead managers on the deal.
